Journal of clinical lipidology
Associations of lipid-lowering drugs with cardiovascular-kidney-metabolic syndrome: A drug-target Mendelian randomization study.
Mengjin Hu, Zhaoting Gong, Xiaosong Li, Jinggang Xia, Chunlin Yin
Published: 202510.1016/j.jacl.2025.10.076
Abstract
OBJECTIVE: Statins, ezetimibe, and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are widely prescribed lipid-lowering agents to reduce low-density lipoprotein cholesterol (LDL-C) and cardiovascular risk. However, their broader impa…
Preview only. Read the full abstract at the source